Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

News & Insight

Ductal carcinoma (breast cancer) high grade.
October 27, 2021/Cancer/News & Insight

Biosignature Predicts Benefit of Adjuvant Radiotherapy in Patients With DCIS

Novel assay identifies women most likely to benefit

19-ORT-1123-Diagnostic-PET-CQD
October 26, 2021/Cancer/News & Insight

18F Fluciclovine PET CT Helps Distinguish Radiation Necrosis from Brain Tumor Progression

Study presented at ASTRO 2021 shows promise in patients treated with stereotactic radiosurgery

ALL_650x450
August 25, 2021/Cancer/News & Insight

Inotuzumab Ozogamicin Improves Outcomes in Patients With Acute Lymphoblastic Leukemia, Independent of CD22 Expression

Drug beats standard care for the treatment of relapsed or refractory ALL

20-NEU-1990660-sleep-symptoms-in-health-workers-650×450
May 14, 2021/Cancer/News & Insight

Key to Work-Life Balance: Just Say No

Oncologist argues the "yes" culture of medicine leads to imbalance

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

breast cancer patient
February 4, 2021/Cancer/News & Insight

Spurred by Pandemic, ASCO Issues Recommendations on Oncology Research and Care

Recommendations focus on streamlining research and improving access to care

Brian Bolwell, MD
January 25, 2021/Cancer/News & Insight

The Cancer Center and Cleveland Clinic’s Centennial

Reflecting on our progress and potential

T-cells_650x450
January 21, 2021/Cancer/News & Insight

Managing CAR T-Cell Therapy Across Cancer Center Programs

Researching and operationalizing a new therapy

Covid-19 vaccine
January 19, 2021/Cancer/News & Insight

COVID-19 mRNA Vaccines: What Does This Mean for Cancer?

Insights from the Director of the Center for Immunotherapy and Precision Immuno-Oncology

Amyloid-fib_650x450
December 18, 2020/Cancer/News & Insight

Combination Therapy for AL Amyloidosis Safe, Tolerable and Promising in Early Results

Cael-101 + CyBorD dosing and outcomes

20-GER-1881817_CQD_650x450_1218158665 (1)
October 15, 2020/Cancer/News & Insight

Beyond Social Distancing: Cancer Care in the Age of COVID-19

Psychosocial and downstream effects

BackPage 5 of 18Next

Advertisement

Ad